Surgery Following EGFR TKI Therapy Shows Potential to Extend Progression-Free Survival in Metastatic NSCLC
(Barcelona, Spain, September 9, 2025, 10:15 a.m. CEST / UTC +2) — Groundbreaking findings from a randomized Phase II clinical ...
(Barcelona, Spain, September 9, 2025, 10:15 a.m. CEST / UTC +2) — Groundbreaking findings from a randomized Phase II clinical ...
In a groundbreaking advancement for the management of advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) ...
Groundbreaking Phase III Trial Demonstrates Superior Efficacy of Aumolertinib Plus Chemotherapy in Advanced EGFR-Mutant NSCLC In a pivotal advancement for ...
In a groundbreaking development in the treatment of advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) ...
In a groundbreaking multicenter retrospective study published in BMC Cancer, researchers have delved into the crucial question of how young ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine